Thomas John Dietz Acquires 4,000 Shares of Eiger Biopharmaceuticals Inc (NASDAQ:EIGR) Stock
Eiger Biopharmaceuticals Inc (NASDAQ:EIGR) Director Thomas John Dietz purchased 4,000 shares of the stock in a transaction on Friday, January...
Eiger Biopharmaceuticals Inc (NASDAQ:EIGR) Director Thomas John Dietz purchased 4,000 shares of the stock in a transaction on Friday, January...
Some more wins of the week Smashburger named Partners & Napier as its creative and media agency of record, following...
Feb 7th, 2020 by Darren Hillock. The Salem School Board is seeking community opinion on the selection of a new...
Share Tweet Share Share Share Print Email SoftBank Group, which is behind the highly successful Vision Fund, is not going...
The Customer Experience Economy is the most violent economy in the history of capitalism. In ten years, Tesla has become more valued than...
H-E-B celebrates its award by paying each employee $100 Would you like to receive...
Price Analysis Feb 7: BTC, ETH, XRP, BCH, BSV, LTC, EOS, BNB, ADA, XTZ Cointelegraph
Friday, February 7, 2020 The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily...
In the News This week California banned the sale of the neurotoxic pesticide chlorpyrifos, used on fruits and vegetables, which...
Alaska Fisheries Science Center on Feb 7, 2020. Theresa Peterson and her family haul in a catch of salmon off Kodiak,...
© 2025 researchsnappy.com